Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $883.27 | 17 | 64.5% |
| Travel and Lodging | $486.65 | 3 | 35.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intersect ENT, Inc. | $778.79 | 4 | $0 (2017) |
| Horizon Therapeutics plc | $125.42 | 1 | $0 (2020) |
| DePuy Synthes Sales Inc. | $124.92 | 1 | $0 (2017) |
| NuVasive, Inc. | $61.58 | 1 | $0 (2018) |
| Optinose US, Inc. | $44.37 | 2 | $0 (2023) |
| Stryker Corporation | $41.41 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $33.83 | 2 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $28.75 | 1 | $0 (2021) |
| HOSPIRA, INC. | $24.34 | 1 | $0 (2017) |
| PolyNovo North America LLC | $21.63 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $46.50 | 2 | Optinose US, Inc. ($24.87) |
| 2022 | $116.63 | 5 | Stryker Corporation ($41.41) |
| 2021 | $62.55 | 3 | Regeneron Healthcare Solutions, Inc. ($28.75) |
| 2020 | $125.42 | 1 | Horizon Therapeutics plc ($125.42) |
| 2019 | $15.99 | 1 | ARBOR PHARMACEUTICALS, INC. ($15.99) |
| 2018 | $61.58 | 1 | NuVasive, Inc. ($61.58) |
| 2017 | $941.25 | 7 | Intersect ENT, Inc. ($778.79) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/06/2023 | PolyNovo North America LLC | — | Food and Beverage | Cash or cash equivalent | $21.63 | General |
| 11/22/2022 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $19.40 | General |
| 10/26/2022 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $16.14 | General |
| 09/12/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/06/2022 | Stryker Corporation | SCOPIS ENT (Device) | Food and Beverage | In-kind items and services | $41.41 | General |
| Category: INSTRUMENTS | ||||||
| 05/26/2022 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2021 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $20.15 | General |
| 10/06/2021 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $13.65 | General |
| 05/19/2021 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $125.42 | General |
| Category: TEPEZZA | ||||||
| 01/04/2019 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Pediatrics/Neonatology | ||||||
| 02/12/2018 | NuVasive, Inc. | — | Food and Beverage | In-kind items and services | $61.58 | General |
| 06/09/2017 | Intersect ENT, Inc. | PROPEL (Device) | Travel and Lodging | Cash or cash equivalent | $411.25 | General |
| Category: Otolaryngology | ||||||
| 06/09/2017 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $292.14 | General |
| Category: Otolaryngology | ||||||
| 06/09/2017 | Intersect ENT, Inc. | PROPEL (Device) | Travel and Lodging | Cash or cash equivalent | $41.40 | General |
| Category: Otolaryngology | ||||||
| 06/09/2017 | Intersect ENT, Inc. | PROPEL (Device) | Travel and Lodging | Cash or cash equivalent | $34.00 | General |
| Category: Otolaryngology | ||||||
| 05/23/2017 | HOSPIRA, INC. | PRECEDEX (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: SEDATIVE | ||||||
| 04/25/2017 | DePuy Synthes Sales Inc. | MATRIXCOMBO (Device), MATRIXNEURO | Food and Beverage | In-kind items and services | $124.92 | General |
| Category: CMF-Trauma | ||||||
| 03/01/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Breakthrough Cancer Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 104 | 121 | $47,029 | $13,527 |
| 2022 | 6 | 129 | 151 | $57,348 | $16,471 |
| 2021 | 6 | 102 | 122 | $43,131 | $12,141 |
| 2020 | 6 | 121 | 154 | $51,215 | $12,327 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 35 | $14,910 | $4,510 | 30.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $12,160 | $3,243 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 27 | $8,559 | $2,562 | 29.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 16 | 21 | $7,476 | $2,034 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 18 | $3,924 | $1,177 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 37 | $15,762 | $4,959 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $12,768 | $3,620 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 31 | $9,827 | $2,872 | 29.2% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 19 | 27 | $9,612 | $2,538 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 24 | $5,232 | $1,297 | 24.8% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 11 | 11 | $4,147 | $1,186 | 28.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 19 | $8,094 | $2,490 | 30.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $9,120 | $2,465 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 31 | $6,758 | $2,110 | 31.2% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 16 | 24 | $8,544 | $2,110 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 22 | $6,974 | $1,978 | 28.4% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 11 | 11 | $3,641 | $988.90 | 27.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 38 | $12,045 | $2,792 | 23.2% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2020 | 19 | 30 | $10,653 | $2,574 | 24.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 39 | $8,502 | $2,114 | 24.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $7,205 | $1,731 | 24.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 15 | $6,390 | $1,587 | 24.8% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2020 | 15 | 17 | $6,420 | $1,528 | 23.8% |
About Dr. Jason Diaz, MD
Dr. Jason Diaz, MD is a Otolaryngology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417144353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Diaz, MD has received a total of $1,370 in payments from pharmaceutical and medical device companies, with $46.50 received in 2023. These payments were reported across 20 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($883.27).
As a Medicare-enrolled provider, Diaz has provided services to 456 Medicare beneficiaries, totaling 548 services with total Medicare billing of $54,466. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Saint Louis, MO
- Active Since 09/25/2007
- Last Updated 01/17/2014
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1417144353
Products in Payments
- PROPEL (Device) $778.79
- TEPEZZA (Drug) $125.42
- MATRIXCOMBO (Device) $124.92
- Xhance (Drug) $44.37
- SCOPIS ENT (Device) $41.41
- LIBTAYO (Biological) $28.75
- PRECEDEX (Drug) $24.34
- BRIDION (Drug) $20.18
- Otovel (Drug) $15.99
- SUBSYS (Drug) $13.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Saint Louis
Dr. Craig Buchman, Md, MD
Otolaryngology — Payments: $523,291
Dr. Ryan Jackson, Md, MD
Otolaryngology — Payments: $247,227
Dr. John Schneider, Md, MD
Otolaryngology — Payments: $109,888
Dr. Ravindra Uppaluri, Md, MD
Otolaryngology — Payments: $102,381
Dr. Cristine Klatt-Cromwell, Md, MD
Otolaryngology — Payments: $15,090
Dr. Bharat Panuganti, Md, MD
Otolaryngology — Payments: $12,293